The original content of Democracy Now! Headlines appears under the Creative
Commons BY-NC-ND 3.0 License (United States). For more, including their other
shows and media, visit www.democracynow.org.
March 20, 2020

Trump Blasts "Corrupt" Media at Rambling Coronavirus Press Conference
---------------------------------------------------------------------

At the White House, President Donald Trump sought to deflect criticism
of his administration's disastrous handling of the coronavirus crisis,
lashing out at China and excoriating the media as "fake" and "corrupt
news." Reporters in Thursday's White House press briefing sat in every
other chair to increase social distancing. Faced with a barrage of
critical questions, Trump threatened to empty the room even further.

President Donald Trump: "You're actually sitting too close. You should -
really, we should probably get rid of about another 75, 80% of you. I'll
have just two or three that I like in this room. I think that's a great
way of doing it. We just figured a new way of doing it. But you're
actually much too close. You know, you two, you should leave
immediately."

Trump gave the final question of Thursday's press briefing to Chanel
Rion, a Republican political operative with the far-right website One
America News.

Chanel Rion: "Is it alarming that major media players, just to oppose
you, are consistently siding with foreign state propaganda, Islamic
radicals and Latin gangs and cartels, and they work right here at the
White House with direct access to you and your team?"

During the press conference, Trump recommended the use of the
anti-malarial drug chloroquine for patients suffering from COVID-19.

President Donald Trump: "We're going to be able to make that drug
available almost immediately. And that's where the FDA has been so
great. They've gone through the approval process. It's been approved."

Moments after Trump made those comments, FDA Commissioner Dr. Stephen
Hahn denied his agency had approved chloroquine for COVID-19 treatment,
saying the drug first needs to be tested in a large clinical trial.
Rising Pharmaceuticals, the New Jersey-based company that produces
chloroquine, doubled the price of the drug after Trump's comments -
before reversing its decision later Thursday.


.